In this setting, TGF-β signaling regulates the cancer–stromal interaction to stimulate tumor growth [9,10], and inhibits T cell- and natural killer (NK) cell-mediated tumor clearance to escape from host immunosurveillance [13,15,16,17]. The gene discussed is TGFB1; the disease is cancer.